One Nucleus, the UK life science membership organisation, has appointed Linda Summerton as a director. She is the chief executive of Immodulon Therapeutics Ltd, a UK immunotherapy company and a former researcher and global product director of AstraZeneca Plc. Dr Summerton earned a PhD in chemistry from the University of Cambridge and did postdoctoral work at the University of California, San Francisco, US.
One Nucleus announced the appointment on 13 February 2017.
Copyright 2017 Evernow Publishing Ltd